Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Allergy is one of the most important and very common health problems worldwide. To reduce the proportion of people suffering from allergy, alternative methods of prevention and treatment are sought. The aim of this paper is to present the possibilities of probiotics in the prevention and treatment of allergic diseases. Probiotics are live microorganisms belonging mainly to the lactic acid bacteria. They modify the microflora of the human digestive system, especially the intestinal microflora. Prophylactic administration of probiotics in the early stages of life (naturally in breast milk or milk substitute synthetic compounds) is very important because intestinal microflora plays a huge role in the development of the immune system. Prevention of allergies as early as in the prenatal and postnatal periods provides huge opportunities for inhibiting the growing problem of allergy in emerging and highly developed societies. Effects of probiotic therapy depend on many factors such as the species of the microorganism used, the dose size and characteristics of the bacteria such as viability and capacity of adhesion to the intestinal walls. Authors of several studies showed beneficial effects of probiotics in the perinatal period, infancy, and also in adults in the prevention of atopic dermatitis or allergic rhinitis. Probiotics, due to their immunomodulatory properties and safety of use are a good, natural alternative for the prevention and treatment of many diseases including allergies. It is therefore important to explore the knowledge about their use and to carry out further clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Probiotic immunomodulation in health and disease
Erickson, K. L., & Hubbard, N. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.403s · Cited by 372 · cited 1×
“Immunological mechanisms of probiotics is associated with reducing the inflammatory response by modifying the presentation of the antigen promoting the differentiation of Th1 cells, NK cells and macrophage activation, increasing the expression of the genes encoding interleukin 8 (IL-8) and tumor necrosis factor α (TNF…”
Cited by
Health benefits of fermented foods
Şanlier, N., Gökcen, B. B., & Sezgin, A. C. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1383355 · Cited by 789
Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions
Coelho, M. C., Malcata, F. X., & Silva, C. C. G. (2022) · Foods · doi:10.3390/foods11152276 · Cited by 276
“The potential benefits of consuming probiotics are primarily due to positive changes in the gut microbiota, known to play a key role upon the immune system [201].”
InfluentialVaginal microbiome: normalcy vs dysbiosis
Saraf, V. S., Sheikh, S. A., Ahmad, A., Gillevet, P. M., Bokhari, H., & Javed, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02414-3 · Cited by 197
Kathiriya, M. R., Vekariya, Y. V., & Hati, S. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10104-3 · Cited by 50
Zhang, C., Zhang, Y., Ma, K., Wang, G., Tang, M., Wang, R., Xia, Z., Xu, Z., Sun, M., Bao, X., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-458 · Cited by 25
“plantarum, have already been designated as “Generally Recognized As Safe” by the United States Food and Drug Administration, and thus are obvious targets for probiotic development (43).”
Background
Metadata
- Authors
- Żukiewicz-Sobczak, W., Wróblewska, P., Adamczuk, P., & Silny, W.
- Venue
- Central European Journal of Immunology
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2014-04-22
- Volume
- 39
- Issue
- 1
- Pages
- 104-108
- ISSN
- 1426-3912 (ISSN-L)
- 1644-4124
- OpenAlex
- W2331486141
- Cited by
- 53
- References
- 2
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. https://app.cochat.ai/papers/10.5114/ceji.2014.42134
- The paper
- Żukiewicz-Sobczak, W., Wróblewska, P., Adamczuk, P., & Silny, W. (2014). Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. Central European Journal of Immunology. https://doi.org/10.5114/ceji.2014.42134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.